SCHEMBL5657528

SCHEMBL5657528

NS(=O)(=O)c1ccc(CCNCCCCNCC(=O)Nc2ccc(Oc3ccccc3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.59
POLB P06746 2/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
CA2 P00918 11/20 0.58
CA1 P00915 10/20 0.58
CA9 Q16790 6/20 0.58
CA12 O43570 5/20 0.58
LTA4H P09960 3/20 0.58
CA4 P22748 2/20 0.54
RECQL P46063 1/20 0.54
TSHR P16473 1/20 0.54
MMP2 P08253 2/20 0.53
MMP8 P22894 2/20 0.53
MMP14 P50281 2/20 0.53
MMP1 P03956 1/20 0.52
MMP9 P14780 1/20 0.52
MMP16 P51512 1/20 0.52
CA7 P43166 1/20 0.52
KDM4E B2RXH2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5662142 0.91 LTA4H (0.70) POLBMEN1KMT2ACA2CA1
SCHEMBL5661814 0.87 LTA4H (0.62) LTA4HRECQLKDM4E
SCHEMBL5659647 0.87 LTA4H (0.62) LTA4HRECQLKDM4E
SCHEMBL5659377 0.86 LTA4H (0.63) LTA4HRECQLKDM4E
SCHEMBL5659737 0.85 LTA4H (0.62) POLBMEN1KMT2ALTA4HRECQL
SCHEMBL5661530 0.84 LTA4H (0.61) MEN1KMT2ALTA4HRECQLKDM4E
SCHEMBL5660688 0.84 LTA4H (0.60) LTA4HRECQLKDM4E
SCHEMBL22069565 0.83 RECQL (0.75) MEN1KMT2ALTA4HRECQLKDM4E
SCHEMBL22069745 0.81 RECQL (0.71) MEN1KMT2ALTA4HRECQLMMP2
SCHEMBL5659837 0.80 RECQL (0.58) POLBLTA4HRECQLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070155727-A1 Amide inhibitors of leukotriene A4 hydrolase SCHERING AKTIENGESSELLSCHAFT (DE) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155727-A1 Amide inhibitors of leukotriene A4 hydrolase LTA4H, LTB4R, LTC4S TAAR1 1227/4885POLB 1455/4885MEN1 4385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.